Robert Kaiser, M.D., associate professor of medicine, was elected to serve on the Board of Directors for the American Academy of Home Care Medicine.
Ian Toma, M.D., MSHS ’04, Ph.D.‘11, associate research professor of clinical research and leadership and medicine, was selected as a Core Fulbright U.S. Scholar to facilitate bioinformatics and genomics education and to conduct a research project in Moldova.
The GW School of Medicine and Health Sciences has established a new Center for Healthcare Innovation and Policy Research. The new Center will absorb the Office of Clinical Practice Innovation and Urgent Matters, expanding its reach across GW.
The GW Cancer Center received a one million dollar grant from the Pfizer Foundation to advance equitable, patient-centered cancer care by providing resources for patients and health care providers to have improved conversations, including a focus on patient health literacy, and cultural sensitivity.
The GW Institute for Spirituality and Health (GWish) celebrates its 15th anniversary this year. GWish is a recognized leader in building the global movement to create more compassionate health care systems.
Researchers from GW have received a $28 million grant from the NIH to lead an 18-site collaboration, named “BELIEVE,” to find a cure for HIV
Jesse Pines, M.D., M.B.A., director of the Center for Healthcare Innovation and Policy Research (CHIPR), as well as other GW CHIPR researchers, created a conceptual model for episodes of acute, unscheduled care. The model, published in Annals of Emergency Medicine, will help researchers, policymakers, payers, patients, and providers identify and prioritize ways to improve acute care delivery.
The GW Cancer Center has joined with nearly 1,000 local and national organizations to support the 80% by 2018 initiative, led by the American Cancer Society, the Centers for Disease Control and Prevention, and the National Colorectal Cancer Roundtable. The 80% by 2018 initiative represents a shared goal to have 80 percent of adults age 50 and over regularly screened for colorectal cancer by 2018.